EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series

Peter Kramer iD, Bernd Opgen-Rhein, Felix Berger, Johannes Nordmeyer

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30747 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Peter Kramer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Congenital Heart Disease - Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany. Hauptthemen laut MEDLINE: Septal Occluder Device, Atrial Fibrillation, Heart Septal Defects, Atrial, Foramen Ovale, Patent. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Device thromboses after patent foramen ovale (PFO) and atrial septal defect (ASD) closure are rare but serious complications. They have been reported in different devices of virtually all manufacturers. Here, we report three cases of left atrial device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder (GSO) in our recent institutional experience. All patients were symptomatic with new‐onset neurological impairments and evidence of cerebral thromboembolism. Device thromboses have occurred despite antiplatelet therapy in two patients and moreover were observed late, at approximately 2 years after implantation, in two patients. One device was surgically explanted while in two cases, thrombi completely resolved with initiated anticoagulation. All patients had a favorable neurological recovery. Our observations suggest that regular follow‐up echocardiography beyond 6 months after device implantation might be advisable in patients with GSO devices to rule out late device thromboses. More long‐term follow‐up data considering safety and late complications of contemporary PFO and ASD devices is required to establish confident evidence‐based recommendations on long‐term follow‐up management and antithrombotic therapy regimen after PFO and ASD closure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Septal Occluder DeviceAtrial FibrillationHeart Septal Defects, AtrialForamen Ovale, PatentThrombosisHumansTreatment OutcomeCardiac CatheterizationProsthesis Design

Stichwörter der Autor:innen

Gore® Cardioform septal occluderdevice thrombosispatent foramen ovale closuresecundum type atrial septal defect closure

Autor:innen und Institutionen

  • Department of Congenital Heart Disease - Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
  • Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.

ORCID-Profile: Peter Kramer

Zitieren

APA

Kramer, P., Opgen-Rhein, B., Berger, F., & Nordmeyer, J. (2023). Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30747

Vancouver

Kramer P, Opgen-Rhein B, Berger F, Nordmeyer J. Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30747

BibTeX
@article{Kramer2023,
  author = {Kramer, Peter and Opgen-Rhein, Bernd and Berger, Felix and Nordmeyer, Johannes},
  title = {Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30747}
}
Kostenlos starten →